ArticleMolecular therapy. Methods & clinical development2015

Inhalable delivery of AAV-based MRP4/ABCC4 silencing RNA prevents monocrotaline-induced pulmonary hypertension.

Caroline Claude et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.